Literature DB >> 27033107

Role of p53, Mitochondrial DNA Deletions, and Paternal Age in Autism: A Case-Control Study.

Sarah Wong1, Eleonora Napoli1, Paula Krakowiak2, Flora Tassone3, Irva Hertz-Picciotto4, Cecilia Giulivi5.   

Abstract

BACKGROUND: The tumor suppressor p53 responds to a variety of environmental stressors by regulating cell cycle arrest, apoptosis, senescence, DNA repair, bioenergetics and mitochondrial DNA (mtDNA) copy number maintenance. Developmental abnormalities have been reported in p53-deficient mice, and altered p53 and p53-associated pathways in autism (AU). Furthermore, via the Pten-p53 crosstalk, Pten haploinsufficient-mice have autisticlike behavior accompanied by brain mitochondrial dysfunction with accumulation of mtDNA deletions.
METHODS: mtDNA copy number and deletions, and p53 gene copy ratios were evaluated in peripheral blood monocytic cells from children aged 2-5 years with AU (n = 66), race-, gender-, and age-matched typically neurodeveloping children (n = 46), and both parents from each diagnostic group, recruited by the Childhood Autism Risk from Genes and Environment study at the University of California, Davis.
RESULTS: mtDNA deletions and higher p53 gene copy ratios were more common in children with AU and their fathers. The incidence of mtDNA deletions in fathers of children with AU was increased 1.9-fold over fathers of typically neurodeveloping children, suggesting a role for deficient DNA repair capacity not driven by paternal age. Deletions in mtDNA and altered p53 gene copy ratios seem to result from genetics (children with severity scores ≥8) and/or act in concert with environmental factors (children with 6-7 severity scores).
CONCLUSIONS: Given pro- and antioxidant activities of p53, and associations of genomic instability with disorders other than AU, our study suggests a link between DNA repair capacity, genomic instability in the 17p13.1 region influenced by environmental triggers, and AU diagnosis.
Copyright © 2016 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27033107      PMCID: PMC4811307          DOI: 10.1542/peds.2015-1888

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  77 in total

1.  Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants.

Authors:  Raquel Moreno-Loshuertos; Rebeca Acín-Pérez; Patricio Fernández-Silva; Nieves Movilla; Acisclo Pérez-Martos; Santiago Rodriguez de Cordoba; M Esther Gallardo; José Antonio Enríquez
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

Review 2.  p53, aerobic metabolism, and cancer.

Authors:  Cory U Lago; Ho Joong Sung; Wenzhe Ma; Ping-yuan Wang; Paul M Hwang
Journal:  Antioxid Redox Signal       Date:  2011-04-14       Impact factor: 8.401

3.  Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study.

Authors:  Hjördis Ósk Atladóttir; Tine Brink Henriksen; Diana E Schendel; Erik T Parner
Journal:  Pediatrics       Date:  2012-11-12       Impact factor: 7.124

4.  Mitochondrial dysfunction in autism.

Authors:  Cecilia Giulivi; Yi-Fan Zhang; Alicja Omanska-Klusek; Catherine Ross-Inta; Sarah Wong; Irva Hertz-Picciotto; Flora Tassone; Isaac N Pessah
Journal:  JAMA       Date:  2010-12-01       Impact factor: 56.272

5.  Early life immune challenge alters innate immune responses to lipopolysaccharide: implications for host defense as adults.

Authors:  Shaun Ellis; Abdeslam Mouihate; Quentin J Pittman
Journal:  FASEB J       Date:  2005-06-22       Impact factor: 5.191

6.  Functional annotation of genes overlapping copy number variants in autistic patients: focus on axon pathfinding.

Authors:  Silvia Sbacchi; Francesco Acquadro; Ignazio Calò; Francesco Calì; Valentino Romano
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

7.  Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior.

Authors:  Damon T Page; Orsolya J Kuti; Chrysa Prestia; Mriganka Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

8.  Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study.

Authors:  Ousseny Zerbo; Ana-Maria Iosif; Cheryl Walker; Sally Ozonoff; Robin L Hansen; Irva Hertz-Picciotto
Journal:  J Autism Dev Disord       Date:  2013-01

9.  Increases in mitochondrial DNA content and 4977-bp deletion upon ATM/Chk2 checkpoint activation in HeLa cells.

Authors:  Rong Niu; Minoru Yoshida; Feng Ling
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

10.  Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53.

Authors:  Eleonora Napoli; Catherine Ross-Inta; Sarah Wong; Connie Hung; Yasuko Fujisawa; Danielle Sakaguchi; James Angelastro; Alicja Omanska-Klusek; Robert Schoenfeld; Cecilia Giulivi
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

View more
  4 in total

Review 1.  Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.

Authors:  Ning Cheng; Jong M Rho; Susan A Masino
Journal:  Front Mol Neurosci       Date:  2017-02-21       Impact factor: 5.639

2.  Circulating Non-Coding RNAs as a Signature of Autism Spectrum Disorder Symptomatology.

Authors:  Salam Salloum-Asfar; Ahmed K Elsayed; Saba F Elhag; Sara A Abdulla
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

3.  Autism spectrum disorder and Li-Fraumeni syndrome: purely coincidental or mechanistically associated?

Authors:  Michaela Kuhlen; Julia Taeubner; Dagmar Wieczorek; Arndt Borkhardt
Journal:  Mol Cell Pediatr       Date:  2017-10-05

Review 4.  Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.

Authors:  Shannon Rose; Dmitriy M Niyazov; Daniel A Rossignol; Michael Goldenthal; Stephen G Kahler; Richard E Frye
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.